This content is machine translated Small cell lung carcinoma Durvalumab approved as first immunotherapy for patients with LS-SCLC Durvalumab has been approved as a monotherapy in Switzerland for the treatment of adult patients with unresectable small cell lung cancer (LS-SCLC, limited-stage small cell lung cancer) whose disease has...…
View Post 3 min This content is machine translated Non-small cell lung cancer Management of locally advanced NSCLC – where are we heading? Lung cancer is the second most common and deadliest type of cancer worldwide. Clinically, non-small cell lung cancer (NSCLC) is the most common pathologic form of lung cancer; approximately one-third…
View Post 5 min This content is machine translated Lung cancer Perioperative therapy for better efficacy Neoadjuvant or adjuvant immunotherapy can improve outcomes in patients with resectable non-small cell lung cancer (NSCLC). It has now been observed that perioperative therapies can combine the benefits of both…
View Post 8 min This content is machine translated Lung cancer An overview of non-small cell lung cancer across all stages The European Lung Cancer Congress is a joint project of major multidisciplinary societies representing thoracic oncology specialists working together to advance science, disseminate education and improve the practice of lung…
View Post 6 min This content is machine translated Non-small cell lung cancer Risk-adapted screening and treatment management Non-small cell lung carcinomas are the most common malignant tumors of the lung. 70–80% of all lung tumors can be assigned to this histology. A distinction can now be made…
View Post 2 min This content is machine translated Schwartz-Bartter syndrome Disruption of osmoregulation – effectively balancing electrolytes Schwartz-Bartter syndrome is characterized by an accumulation of water in the body, triggered by an increased release of ADH or ADH-like substances. Nausea, vomiting, headaches and muscle cramps can be…
View Post 4 min This content is machine translated Lung cancer Focus topics: Brain metastases, therapy response and PD-L1 expression Therapy management for lung cancer is entering a new era. The progress made is remarkable and sheds new light on the importance of tumor tests in diagnosis. Many insights have…
View Post 6 min This content is machine translated Oncology Multidisciplinary and cross-indication – the latest trends The central task of the European Society for Medical Oncology (ESMO) is to improve the quality of cancer treatment, cancer prevention and diagnosis as well as palliative care and aftercare…
View Post 3 min This content is machine translated Multiple Myeloma Individualized treatment management on the rise The formation of brain metastases is a dreaded development, especially in lung cancer. There is also an increasing focus on gender-specific differences in medicine. Multiple myeloma also has variables that…
View Post 2 min This content is machine translated SCLC Small cell lung cancer in everyday therapy – an update Small cell lung carcinomas must be treated quickly – they usually grow rapidly and form metastases early on. The diagnosis is therefore often only made at an advanced stage. Lung…
View Post 12 min This content is machine translated The ageing lung Cellular ageing and senescence What are the causes that lead to an inadequate response to insults? How does an organ like the lung change with age, making the older population more susceptible to age-related… CME-Test
